Home News Bulk Drug

Bulk Drug

Alembic Pharma gets USFDA nod for Darifenacin Extended Tablets

Mumbai, December 14, 2017: Pharma Major, Alembic Pharmaceuticals said that it company received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Darifenacin extended release tablets, 7. 5mg and 15mg. Darifenacin extended release...

Dangers of commonly prescribed painkillers highlighted A recent study done by Newcastle University

New Delhi, December 12, 2017: Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed Over the past 10 years, there has been a...

Strides Shasun subsidiary receives USFDA approval for Acetazolamide tablets

Mumbai, November 27, 2017: Pharma Major,Strides Shasun's said that its wholly owned subsidiary Strides Pharma Global has received approval from the United States Food & Drug Administration (USFDA) for Acetazolamide Tablets USP, 125 mg and 250 mg., a generic version of Diamox Tablets. The...

India’s dependence on imports for bulk drugs and APIs

New Delhi, May 09, 2015: As per the Boston Consulting Group Report of 2013 import of Active Pharmaceutical Ingredients (APIs) during the year 2013 was approximately US $ 3.5 billion of which a large share was from China. The...

WOCKHARDT ISSUES A VOLUNTARILY RECALL OF ANTI-HYPERTENSIVE DRUGS FROM US MARKET

New Delhi, June 18, 2014 - Wockhardt Ltd. has issued a voluntary recall of 8,712 bottles of anti-hypertensive drug Metoprolol Succinate extended-release tablets from the US market due to failure of a dissolution test. According to US Food and...

ANTI-ALLERGIC DRUGS RECALLED BY ZYDUS CADILA FROM US MARKET

New Delhi, June 12, 2014 - Zydus Cadila issued a voluntary recall of nearly 10,200 bottles of an anti-allergic drug from the US market. The recall was started by the company’s US unit, Zydus Pharmaceuticals USA Inc. due to...

GSK-Dr Reddy’s to file for joint drug this year

Hyderabad February 19, 2014:- The first drug being jointly developed by GlaxoSmithKline (GSK) and Dr Reddy’s Laboratories will be filed for registration in this year. Speaking to newspersons on the sidelines of the ongoing BioAsia 2014 here on Tuesday,...